)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Basilea Pharmaceutica
Basilea Pharmaceutica (BSLN) investor relations material
Basilea Pharmaceutica Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor presentation summary5 Aug, 2026
Company overview and leadership
Profitable Swiss biopharmaceutical firm focused on anti-infectives, spun off from Roche in 2000, with about 190 employees and listed on SIX Swiss Exchange.
Executive team with deep industry experience across R&D, clinical, and commercial functions.
Strategic focus and business model
Concentrates on severe bacterial and fungal diseases with high unmet medical need, targeting resistance and lack of effective therapies.
Asset-light, capital-efficient model leveraging partnerships, non-dilutive funding, and limited upfront costs.
Generates revenue through product sales, royalties, and milestone payments, with global commercial partners.
Market drivers and unmet needs
Rising incidence of invasive infections due to aging, immunosuppression, medical advances, resistance, and climate change.
Focus on pathogens with limited treatment options and growing resistance, such as Candida, Aspergillus, and multidrug-resistant bacteria.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Basilea Pharmaceutica
- Strong revenue growth, robust pipeline, and global leadership in anti-infectives drive future expansion.BSLN
Investor presentation - Late-stage anti-infective pipeline and global sales growth position for doubling sales by 2030.BSLNInvestor presentation
- Late-stage anti-infective pipeline and strong cash flows drive outlook for doubling sales by 2030.BSLNInvestor presentation
- Innovative anti-infectives pipeline and strong financials position for sustained growth.BSLNInvestor presentation
- Late-stage pipeline and global brands position for strong growth and doubled sales potential.BSLNInvestor presentation
- Strong 2025 revenue and cash growth, pipeline expansion, and funding support future gains.BSLNH2 2025
- Revenue up 36% and operating profit up 160% on strong anti-infective sales and US expansion.BSLNH1 2025
- Upgraded 2024 guidance follows strong Cresemba sales, Zevtera US approval, and pipeline growth.BSLNH1 2024
- Operating profit tripled in 2024 as Cresemba and Zevtera drove record revenue and pipeline growth.BSLNH2 2024
Next Basilea Pharmaceutica earnings date
H1 202618 Aug, 2026
Basilea Pharmaceutica
Next Basilea Pharmaceutica earnings date
H1 202618 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage